Laboratorios Ojer Pharma is a New Technology-Based Company (NEBTs) that focuses all its efforts on the development of innovative pharmaceutical products .
Authorization for phase IIa clinical trial has been granted for Keramod Gel, an innovative bioadhesive product which has been designed and developed as a semisolid filmforming formulation for the treatment of Actinic Keratosis. #KeramodGel#clinicaltrial#Actinickeratosis
Sala llena en la presentación de @OjerPharma en exclusiva para los inversores de @TheCrowdAngel en colaboración con @inveready
¡Estate atento que la semana que viene va a estar disponible en la plataforma!
#OjerPharma y #ReigJofre obtienen la primera autorización europea para la comercialización de su innovador antibiótico Impetine Gel. https://t.co/XFQTjj3D01
¡Enhorabuena! 👏